According to officials, a 10 percent growth is expected by the end of FY23. The pharma exports to European Union and other CIS countries which were hit by the ongoing war in Ukraine and restrictions are expected to improve once the situation becomes normal, reported PTI citing Udaya Bhaskar, Director General of Pharmaceuticals Export Promotion Council of India (Pharmexcil).from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3o9eRkd
via IFTTT
0 comments:
Post a Comment